barr 200mg 588 Pill - green & white capsule/oblong, 18mm
Pill with imprint barr 200mg 588 is Green & White, Capsule/Oblong and has been identified as Didanosine 200 mg. It is supplied by Teva Pharmaceuticals USA.
Didanosine is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for barr 200mg 588
Didanosine
- Imprint
- barr 200mg 588
- Strength
- 200 mg
- Color
- Green & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00555-0588 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
croscarmellose sodium,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
hypromellose 2910 (50 mPa.s),
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polydextrose,
polyethylene glycol 8000,
propylene glycol,
shellac,
silicon dioxide,
sodium hydroxide,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate,
D&C Red No. 33,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about didanosine
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.